Skip to main content
New Horizon Biotech Ltd.
New Horizon Biotech Ltd.
Your life is our life
  • Advancing Diabetes Care with Smarter Medical Device Solutions

    New Horizon Biotech Ltd. develops reliable diabetes management technologies for modern healthcare markets. With expertise spanning product development, manufacturing, and regulatory coordination, we are committed to delivering practical, high-quality solutions that support patients, providers, and partners worldwide.

Who We Are

Diabetes Technologies
Global Operations
Quality & Reliability
Diabetes Technologies

New Horizon Biotech is focused on advancing diabetes management technologies for modern healthcare markets. Through a portfolio centered on insulin delivery, continuous glucose monitoring, and blood glucose monitoring solutions, we aim to support practical, dependable technologies that respond to the evolving needs of patients, providers, and partners worldwide.

Global Operations

New Horizon Biotech maintains a globally connected operating model that supports coordination across product development, manufacturing, regulatory alignment, and market-facing activities. By linking capabilities across key international locations, we strive to strengthen responsiveness, improve operational consistency, and support the needs of diverse healthcare markets.

Quality & Reliability

New Horizon Biotech is committed to maintaining high standards of quality and reliability across its operations. By aligning product design, manufacturing discipline, and operational consistency, we strive to deliver dependable medical device solutions that meet the expectations of partners and healthcare markets worldwide.

Our Products

New Horizon Biotech develops diabetes management technologies designed to support reliable care, operational scalability, and evolving market needs across global healthcare environments.

HorizonFlow Insulin Pump

HorizonFlow is NHB’s established insulin pump platform, developed to support reliable daily diabetes management. As a mature electromechanical device, it remains a core product line within the company’s portfolio, combining proven functionality with ongoing attention to product continuity, manufacturing support, and long-term market relevance.

Learn More

HorizonGuard CGM

HorizonGuard is NHB’s continuous glucose monitoring platform, designed to support modern diabetes care through high-volume sensor capability and strong product adaptability. It reflects the company’s focus on connected diabetes technologies and the growing demand for more responsive glucose monitoring solutions.

Blood Glucose Monitoring System (BGMS)

NHB’s Blood Glucose Monitoring System expands the company’s diabetes portfolio with a practical solution for routine glucose measurement. This product line supports broader portfolio coverage while reinforcing NHB’s commitment to accessible, dependable, and market-ready diabetes care technologies.

Our Markets

New Horizon Biotech serves a globally connected market footprint across China, the United States, the European Union, and Australia. With global headquarters and primary manufacturing operations in Shenzhen, commercial and regulatory coordination in Seattle, EU compliance and late-stage customization support in Budapest, and logistics capabilities in Monterrey, NHB is positioned to support diverse healthcare markets through a flexible international operating model.

Learn More About New Horizon Biotech